TickerFactsScreenerDevelopers

Sarepta Therapeutics, Inc. (SRPT) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $931.0K2010: $832.0K2011: $1.18M2012: $108.0K2013: $2.37M2014: $25.44M2015: $3.40M2016: $5.34M2017: $12.00M2018: $61.16M2019: $59.63M2020: $82.20M2021: $38.49M2022: $30.82M2023: $76.11M2024: $136.96M2025: $101.97M$101.97M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$101.97M-25.5%
2024$136.96M+80.0%
2023$76.11M+146.9%
2022$30.82M-19.9%
2021$38.49M-53.2%
2020$82.20M+37.9%
2019$59.63M-2.5%
2018$61.16M+409.6%
2017$12.00M+124.7%
2016$5.34M+57.0%
2015$3.40M-86.6%
2014$25.44M+973.6%
2013$2.37M+2094.4%
2012$108.0K-90.8%
2011$1.18M+41.6%
2010$832.0K-10.6%
2009$931.0K—